ArticleBasic research in cardiology2025

Evolocumab attenuates myocardial ischemia/reperfusion injury by blocking PCSK9/LIAS-mediated cuproptosis of cardiomyocytes.

Zi-Zhuo Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.